ATNM
AMEX · Biotechnology
Actinium Pharmaceuticals Inc
$0.98
-0.01 (-1.01%)
Open$0.98
Previous Close$0.99
Day High$1.00
Day Low$0.95
52W High$1.89
52W Low$0.94
Volume—
Avg Volume143.5K
Market Cap29.81M
P/E Ratio—
EPS$-0.75
SectorBiotechnology
Analyst Ratings
Strong Buy
11 analysts
Price Target
+3,584.7% upside
Current
$0.98
$0.98
Target
$36.11
$36.11
$23.47
$36.11 avg
$39.96
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 87.3K | 196.8K | 4.99M |
| Net Income | -32,705,574 | -66,339,906 | -1,193,914 |
| Profit Margin | -37,652.2% | -35,769.6% | -23.9% |
| EBITDA | -34,816,096 | -74,544,266 | -1,575,968 |
| Free Cash Flow | — | — | -691,464 |
| Rev Growth | -55.6% | -55.6% | +20.9% |
| Debt/Equity | 0.00 | 0.00 | 0.67 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $251.64 | -1.05% | 118.2 | 429.58B |
| AMGN | Amgen Inc | $362.12 | +0.44% | 24.8 | 193.10B |
| GILD | Gilead Sciences Inc | $126.34 | +0.01% | 17.1 | 157.21B |
| VRTX | Vertex Pharmaceuticals Inc | $496.73 | -0.58% | 28.1 | 121.87B |
| REGN | Regeneron Pharmaceuticals | $623.54 | -1.31% | 15.0 | 66.35B |
| ALNY | Alnylam Pharmaceuticals Inc | $301.03 | +2.56% | 69.3 | 39.97B |